Evidence map›Paper›PMID 28507230›Full record

ArticlePhilosophical transactions. Series A, Mathematical, physical, and engineering sciences2017

Computational design of treatment strategies for proactive therapy on atopic dermatitis using optimal control theory.

Panayiotis Christodoulides, Yoshito Hirata, Elisa Domínguez-Hüttinger, Simon G Danby, Michael J Cork, Hywel C Williams, Kazuyuki Aihara, Reiko J Tanaka

Open access · hybridAbstract read
In one paragraph

Article in Philosophical transactions. Series A, Mathematical, physical, and engineering sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Current research landscape and future prospects of in silico modeling approaches for atopic dermatitis.JID innovations : skin science from molecules to population health · 2026
    Review
  3. Biotechnologia · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Mathematical methods in medicine: neuroscience, cardiology and pathology.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Panayiotis ChristodoulidesDepartment of Bioengineering, Imperial College London, London SW7 2AZ, UK.
Yoshito HirataInstitute of Industrial Science, University of Tokyo, Tokyo 153-8505, Japan.
Elisa Domínguez-HüttingerEcology Institute, National Autonomous University of Mexico, Mexico City 04510, Mexico.
Simon G DanbySchool of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK.
Michael J CorkSchool of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK.
Hywel C WilliamsCentre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK.
Kazuyuki AiharaInstitute of Industrial Science, University of Tokyo, Tokyo 153-8505, Japan.
Reiko J TanakaDepartment of Bioengineering, Imperial College London, London SW7 2AZ, UK r.tanaka@imperial.ac.uk.ORCID http://orcid.org/0000-0002-0769-9382
Imperial College London · GBUniversity of Sheffield · GBUniversidad Nacional Autónoma de México · MXUniversity of Nottingham · GB

Funding

National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/P00217X/1
6 · The paper itself

Abstract

Atopic dermatitis (AD) is a common chronic skin disease characterized by recurrent skin inflammation and a weak skin barrier, and is known to be a precursor to other allergic diseases such as asthma. AD affects up to 25% of children worldwide and the incidence continues to rise. There is still uncertainty about the optimal treatment strategy in terms of choice of treatment, potency, duration and frequency. This study aims to develop a computational method to design optimal treatment strategies for the clinically recommended 'proactive therapy' for AD. Proactive therapy aims to prevent recurrent flares once the disease has been brought under initial control. Typically, this is done by using an anti-inflammatory treatment such as a potent topical corticosteroid intensively for a few weeks to 'get control', followed by intermittent weekly treatment to suppress subclinical inflammation to 'keep control'. Using a hybrid mathematical model of AD pathogenesis that we recently proposed, we computationally derived the optimal treatment strategies for individual virtual patient cohorts, by recursively solving optimal control problems using a differential evolution algorithm. Our simulation results suggest that such an approach can inform the design of optimal individualized treatment schedules that include application of topical corticosteroids and emollients, based on the disease status of patients observed on their weekly hospital visits. We demonstrate the potential and the gaps of our approach to be applied to clinical settings.This article is part of the themed issue 'Mathematical methods in medicine: neuroscience, cardiology and pathology'.

Indexed as

Models, BiologicalAdministration, CutaneousAlgorithmsAnti-Inflammatory AgentsComputer SimulationDermatitis, AtopicDermatologic AgentsDose-Response Relationship, DrugDrug Administration ScheduleDrug MonitoringDrug Therapy, Computer-AssistedHumansSkinTreatment OutcomeAnti-Inflammatory AgentsDermatologic Agentsatopic dermatitisdifferential evolutionmathematical modeloptimal control theorypersonalized treatmenttreatment schedule

Identifiers

PMID28507230
PMCPMC5434076
OpenAlexW2615092492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.